| AChE | acetylcholinesterasese |
| AMP | antimicrobial peptides |
| BAC | benzalkonium chlorides |
| BBB | blood–brain barrier |
| BChE | butyrylcholinesterase |
| CFU | colony-forming unit |
| CNS | central nervous system |
| CPC | cetylpyridinium chloride |
| GS | gemini surfactants |
| G+ | Gram-positive |
| G− | Gram-negative |
| HAP | hypoxia-activated prodrugs |
| IC50 | half-maximal inhibitory concentration |
| LPS | lipopolysaccharides |
| MBC | minimum bactericidal concentration |
| MIC | minimum inhibitory concentration |
| mAChR | muscarinic acetylcholine receptor |
| MMP | matrix metalloproteinases |
| MRSA | methicillin-resistant Staphylococcus aureus |
| nAChR | nicotinic acetylcholine receptor |
| NMBAs | neuromuscular blocking agents |
| PAM | positive allosteric modulator |
| PDT | photodynamic therapy |
| PARP-1 | poly(ADP-ribose) polymerase |
| QA | auaternary ammonium |
| QACs | auaternary ammonium compounds |
| TMV | tobacco mosaic virus |
| VRE | vancomycin-resistant enterococci |